MedPath

REduced Pain After Bariatric Surgery - Sleeve Gastrectomy

Not Applicable
Completed
Conditions
Acute Pain
Postoperative Pain
Analgesia
Pain
Bariatric Surgery Candidate
Anesthesia
Registration Number
NCT06383234
Lead Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Brief Summary

This study aims to analyze the effect of laparoscopic guided transversus abdominis plane (LG-TAP) block compared to placebo for postoperative analgesia following laparoscopic sleeve gastrectomy. One group of participants received a (LG-TAP) block with local anesthetic while the other group received (LG-TAP) block with saline solution (placebo).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Elective Laparoscopic Sleeve Gastrectomy
  • Body Mass Index (BMI) > 35 kg/m² and at least one condition related to obesity (e.g., hypertension, type II diabetes, dyslipidemia, hepatic steatosis, etc)
  • BMI > 40 kg/m², even in the absence of comorbidities
  • ASA physical status score < 4
Exclusion Criteria
  • ASA physical status score ≥ 4
  • Patient's refusal or inability to sign the informed consent
  • Allergies to any drug provided by the study protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain Score24 hours

A numerical rating scale (NRS) from 0 (no pain) to 10 (worst imaginable pain) will be used to evaluate pain at rest during 24 hours after surgery

Secondary Outcome Measures
NameTimeMethod
Nausea and/or vomiting48 hours

Incidence of nausea and/or vomiting

Time to walking72 hours

Time between surgery and patient starting to walk

Surgical Complication7 days

Incidence of complications related to surgery

Time to first flatus72 hours

Time between surgery and patient having flatus

Morphine Consumption24 hours

Total of intravenous morphine (expressed in milligrams) administered administered during the first 24 hours after surgery

Toradol Consumption24 hours

Total of intravenous toradol (expressed in milligrams) administered administered during the first 24 hours after surgery

Lenght of Hospital Stay72 hours

Time between surgery and dismission from the hospital

Trial Locations

Locations (1)

Fondazione Policlinico Universitario Campus Bio-medico

🇮🇹

Rome, Italy

Fondazione Policlinico Universitario Campus Bio-medico
🇮🇹Rome, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.